Head to head for first-timers
CoreAge Rx vs TMates
CoreAge Rx and TMates both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxTMates
Rank #61 for first-timers · Grade C
Mama-Match
Best for: Someone who wants the dose ladder to stop mattering to the bill and prefers the commitment terms disclosed before checkout.
Visit TMatesThe verdict for a first step
CoreAge Rx edges out TMates on the Mama-Match Score, 73 to 67 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
TMates is still a genuine option — compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | TMates |
|---|---|---|
| Mama-Match Score | 73/100 · C | 67/100 · C |
| Overall rank | #31 | #61 |
| Semaglutide | $99/mo | $249/mo |
| Tirzepatide | $149/mo | $297/mo |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
TMates
Rank #61 · Grade C
What we like
- One price per molecule across every dose, so titrating up never raises the bill
- Oral and injectable cost exactly the same, which is rare and removes a hidden penalty for choosing the pill
- Publishes the full three, six and twelve-month ladder with the real totals, not just a per-month figure
The caveats
- Publishes no list of the states it serves, so availability is unknown until you start
- The longer terms are prepaid commitments, so the cheapest per-month numbers are not month-to-month prices
- No postpartum, breastfeeding or PCOS guidance published anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and TMates with the other providers we review for women.
Or browse the full comparison hub.